From our MPN Ask the Expert series, Patient Power viewer, Maryse, asks a question about the MPL mutation and if there are targeted treatments being developed for this mutation. Dr. Prithviraj Bose from The University of Texas MD Anderson Cancer Center responds by explaining the MPL mutations as it relates to others like JAK2 and CALR and goes on to discuss treatments that are meant to target the JAK-STAT pathway.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Advertisement